Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jian Gu"'
Autor:
Feng Li, Yongqing Tong, Jian Gu, Bin Qiao, Jingwei Wang, Hongyun Zheng, Zhijun Zhao, Yan Zhang, Anyu Bao, Siqing Mei, Zegang Wu, Zhen Chen, Xiaoyun He, Liang Xiong
Publikováno v:
Medicine
The outbreak and widely spread of coronavirus disease 2019 (COVID-19) has become a global public health concern. COVID-19 has caused an unprecedented and profound impact on the whole world, and the prevention and control of COVID-19 is a global publi
Publikováno v:
Immunotherapy. 10:1293-1302
Aim: We conducted a meta-analysis to systematically review the efficacy and safety of programmed cell death 1 (PD-1) inhibitors for advanced melanoma. Study design: The relevant studies of the randomized controlled trials in melanoma patients treated
Publikováno v:
Future oncology (London, England). 15(31)
Aim: We conducted an up-to-date meta-analysis of randomized controlled trials (RCTs) to compare the immune checkpoint inhibitors (ICIs) in different age groups. Methods: The relevant RCTs in cancer patients receiving ICIs were searched and the system
Autor:
Wenhu Zhao, Xinzheng Dai, Xintong Wang, Dongliang Wang, Lei Yue, Erhong Meng, Yongjiu Dai, Guojun Li, Xinyin Han, Jian Gu, Siyao Liu
Publikováno v:
Medicine
Rationale: Gallbladder carcinoma is a malignant biliary tract tumor which is characterized by poor prognosis. Recent advances in genomic medicine have identified a few novel germline mutations that contribute to the increased risk of gallbladder carc
Publikováno v:
European Journal of Clinical Pharmacology. 73:1209-1217
We performed a meta-analysis to systematically review the gastrointestinal (GI) events (diarrhea, nausea, vomiting, anorexia) of five newly approved (after 2011) VEGFR-TKIs in cancer patients. The relevant studies of the randomized controlled trials
Publikováno v:
Oncotarget
// Fangfang Wang 1, * , Xiaoyan Xie 1, * , Xiaoming Yang 2 , Guoqing Jiang 3 and Jian Gu 1 1 Department of Hematology, Clinical Medical College of Yangzhou University, Subei People’s Hospital of Jiangsu Province, Yangzhou, China 2 Medical Departmen
Publikováno v:
Critical reviews in oncology/hematology. 119
A meta-analysis was conducted to systematically review the risk of hand-foot skin reaction (HFSR) with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) in patients with cancer. The relevant studies of the randomized
Autor:
Jian Gu, Hua Zhao, David W. Chang, Lixia Han, Carrie R. Daniel, Wong Ho Chow, Jie Shen, Xifeng Wu, Yuanqing Ye
Publikováno v:
Oncotarget
// Hua Zhao 1 , Lixia Han 1 , David Chang 1 , Yuanqing Ye 1 , Jie Shen 1 , Carrie R. Daniel 1 , Jian Gu 1 , Wong-Ho Chow 1 and Xifeng Wu 1 1 Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Correspondenc
Publikováno v:
International journal of clinical oncology. 22(5)
The fatigue associated with five newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) (regorafenib, vandetanib, cabozantinib, lenvatinib, axitinib) is poorly understood. We conducted this systematic revie
Autor:
Christopher Wen, Jack A. Roth, Shuanbei Wu, Sonia A. Cunningham, Maosheng Huang, Chi Pang Wen, Xifeng Wu, Jian Gu, Chwen Keng Tsao, Wong Ho Chow, Min Kwang Tsai, Xia Pu, Yuanqing Ye, Chad D. Huff, Scott M. Lippman
Publikováno v:
Scientific Reports
Scientific reports, vol 6, iss 1
Scientific reports, vol 6, iss 1
The objective of this study was to develop markedly improved risk prediction models for lung cancer using a prospective cohort of 395,875 participants in Taiwan. Discriminatory accuracy was measured by generation of receiver operator curves and estim